Lipid Metabolism Disorder

Lipid Metabolism Disorder(来自ICD-11)
别称:
Dyslipidemia
Disorder of Fatty Acid Metabolism
Lipid Metabolism Disorders
Congenital Disorders of Lipid Metabolism
Inherited Disorders of Lipid Metabolism
Abnormality of Lipid Metabolism
Lipid Metabolism, Inborn Errors
Fatty Acid Metabolism Disorder
Fatty-Acid Metabolism Disorder
Disorders of Lipid Metabolism
Disorder of Lipid Metabolism
Dyslipidemias
加入收藏
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Lipid Metabolism Disorder, also known as dyslipidemia, is related to hyperlipoproteinemia, type iii and hypobetalipoproteinemia, familial, 1. An important gene associated with Lipid Metabolism Disorder is LIPC (Lipase C, Hepatic Type), and among its related pathways/superpathways are Metabolism and Transport of inorganic cations/anions and amino acids/oligopeptides. The drugs Pitavastatin and Valsartan have been mentioned in the context of this disorder. Affiliated tissues include liver and bone marrow, and related phenotypes are Increased free cholesterol and Increased LDL uptake
查看原文 参与反馈
相关ID:
MESH:D008052
ICD11:182578312

基础信息

遗传方式
发病时间
患病率/发病率
相关基因
相关模型
参考文献
MALACARDS
--
Unknown
--
127
1441
3

疾病表征

#
分类
表征
HPO概率
Orphanet概率
HPO来源
暂无相关数据

基因 & 突变

#
基因
作用分类
分值
突变数量
暂无相关数据

靶点药物

药物名称
CAS号
研发状态
临床阶段
暂无相关数据

疾病模型

类型
名称
MGI
相关基因
品系来源
文献数量
暂无相关数据

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top